false
Catalog
Session II: Intractable Pain, Opioid Failure and t ...
Recording
Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The presentation focused on the complexities of managing sickle cell disease, particularly the challenges associated with pain management and opioid use. The session began with disclosures and information on how participants could earn continuing education credits. Christine Tekel-Heimanot, a nurse practitioner, shared her experience in treating patients with sickle cell disease, emphasizing the importance of understanding and addressing total pain, which includes physical, social, psychological, and spiritual aspects. She discussed the traditional use of opioids in managing pain and highlighted the concept of "opioid failure," wherein opioids no longer effectively manage a patient's pain or functional goals.<br /><br />Christine shared a case study of a patient suffering from opioid failure and highlighted the complexities involved, such as the patient's mental health issues and substance misuse. She advocated for a multidisciplinary approach and the use of buprenorphine as an alternative for pain management, which the patient eventually agreed to, showing marked improvement.<br /><br />Dr. Prasad continued by discussing the importance of cognitive-behavioral therapy (CBT) and relaxing strategies in managing pain. He illustrated how stress can exacerbate pain and explained the role of the nervous system in this process. The session concluded with a Q&A, reinforcing the need for an interdisciplinary approach and patient-specific strategies in managing chronic pain effectively.
Keywords
sickle cell disease
pain management
opioid use
opioid failure
multidisciplinary approach
buprenorphine
cognitive-behavioral therapy
total pain
interdisciplinary strategies
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English